Jason Comander, MD, PhD (IMAGE)
Caption
Jason Comander, MD, PhD, director of the Inherited Retinal Disorders Service at Mass Eye and Ear, examines the CRISPR-based medicine prior to performing a surgery of the novel treatment in September 2020, at Mass Eye and Ear in Boston.
Credit
Mass Eye and Ear
Usage Restrictions
Please credit Mass Eye and Ear
License
Original content